| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | October 7, 2021 4:30 P.M. |
| Form: | S-1 | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | October 7, 2021 4:30 P.M. |
| Form: | S-1 | ||||||
| |||||||
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
4 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)
3 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)
3 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)
WILMINGTON, Del., Sept. 30, 2025 /PRNewswire/ -- Blue Water Venture Partners, LLC ("Blue Water"), an entity affiliated with Joseph Hernandez, the Chairman and Chief Executive Officer of Blue Water Acquisition Corp III ("BWAC III") announced today that it has formally requested approval from the United States District Court for the District of Delaware to consider its unsolicited $10 billion bid for the assets of CITGO Petroleum Corporation. The motion, filed September 12, 2025, in the matter of Crystallex International Corp. v. Bolivarian Republic of Venezuela (Case No. 17-mc-
In the news release, Blue Water Advances in CITGO Bidding Process, issued 15-Sep-2025 by Blue Water Acquisition Corp iii over PR Newswire, we are advised by the company that the media contact was omitted from the text. The complete, corrected release follows: Blue Water Advances in CITGO Bidding Process NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Blue Water Venture Partners, LLC ("Blue Water"), an entity affiliated with Joeseph Hernandez, the Chairman and Chief Executive Officer of Blue Water Acquisition Corp. III (Nasdaq: "BLUWU"), announced today that it has received court approval to enter into a non-disclosure agreement with the Special Master, granting access to the confidential data ro
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Blue Water Venture Partners, LLC ("Blue Water"), an entity affiliated with Joeseph Hernandez, the Chairman and Chief Executive Officer of Blue Water Acquisition Corp. III (Nasdaq: "BLUWU"), announced today that it has received court approval to enter into a non-disclosure agreement with the Special Master, granting access to the confidential data room established for the CITGO sale. Blue Water continues to assert that its proposal represents the most compelling and beneficial path forward for all stakeholders. Blue Water's $10 billion b
10-Q - Blue Water Acquisition Corp. III (0002050501) (Filer)
SCHEDULE 13G - Blue Water Acquisition Corp. III (0002050501) (Subject)
SCHEDULE 13G - Blue Water Acquisition Corp. III (0002050501) (Subject)
SC 13G/A - Clarus Therapeutics Holdings, Inc. (0001817944) (Subject)
SC 13G - Clarus Therapeutics Holdings, Inc. (0001817944) (Subject)
SC 13D - Clarus Therapeutics Holdings, Inc. (0001817944) (Subject)